Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DR26FG1CY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,561
Award facts
- Contract value 100% obligated
- $32,560.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,560.78 to AmerisourceBergen Drug Corp for the supply of XGEVA 120 mg/1.7 ml vials. The contract was awarded on November 17, 2025, with an ultimate completion date of November 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively through the contractor's existing indefinite delivery contract vehicle with DLA.
This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger $999.99 billion indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive contract portfolio with DLA demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. XGEVA (denosumab) is a bone-targeted agent used in oncology, indicating this delivery is supporting federal healthcare needs within the military health system.
Quick answers
Who was awarded contract SPE2DR26FG1CY?
SPE2DR26FG1CY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FG1CY worth?
The government has obligated $32,561 on SPE2DR26FG1CY.
Is contract SPE2DR26FG1CY an order under another contract?
Yes. SPE2DR26FG1CY is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1CY competed?
The extent of competition for SPE2DR26FG1CY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award